Skip to main content

Jen JenYehMD

General Surgery • Chapel Hill, NC

Endocrine, Melanoma, Pancreas, Surgical Oncology (Other than Breast)

Professor, Departments of Surgery and Pharmacology, University of North Carolina-Chapel Hill School of Medicine; Vice Chair for Research, Department of Surgery

Join to view full profile

Dr. Yeh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Yeh's full profile

Already have an account?

  • Office

    101 Manning Dr
    Chapel Hill, NC 27599
    Phone+1 919-966-8596
    Fax+1 919-843-5515

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2003 - 2005
  • Boston University Medical Center
    Boston University Medical CenterResidency, Surgery, 1996 - 2003
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1996

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Press Mentions

  • Rashid Awarded Grant to Develop AI Tool That Recommends Optimal Clinical Trials to Pancreatic Cancer Patients
    Rashid Awarded Grant to Develop AI Tool That Recommends Optimal Clinical Trials to Pancreatic Cancer PatientsSeptember 24th, 2024
  • Device Targets Hard-to-Treat Pancreatic Cancer
    Device Targets Hard-to-Treat Pancreatic CancerFebruary 24th, 2016
  • Device Hits Pancreatic Tumors Hard with Toxic Four-Drug Cocktail, Sparing the Body
    Device Hits Pancreatic Tumors Hard with Toxic Four-Drug Cocktail, Sparing the BodyFebruary 8th, 2016
  • Join now to see all

Grant Support

  • Targeted EGFR for basal subtype pancreatic cancerUNIV OF NORTH CAROLINA CHAPEL HILL2024–2029
  • Targeted EGFR for basal subtype pancreatic cancerUNIV OF NORTH CAROLINA CHAPEL HILL2024–2029
  • UNC Integrated Translational Oncology Program (UNC-iTOP)UNIV OF NORTH CAROLINA CHAPEL HILL2019–2029
  • UNC Integrated Translational Oncology Program (UNC-iTOP)UNIV OF NORTH CAROLINA CHAPEL HILL2019–2029
  • Selective Targeting of Pancreatic Cancer SPOREUNIV OF NORTH CAROLINA CHAPEL HILL2022–2027
  • Integrating tumor and stroma to understand and predict treatment responseUNIV OF NORTH CAROLINA CHAPEL HILL2022–2027
  • Selective Targeting of Pancreatic Cancer SPOREUNIV OF NORTH CAROLINA CHAPEL HILL2022–2027
  • Selective Targeting of Pancreatic Cancer SPOREUNIV OF NORTH CAROLINA CHAPEL HILL2022–2027
  • Integrating tumor and stroma to understand and predict treatment responseUNIV OF NORTH CAROLINA CHAPEL HILL2022–2027
  • Selective Targeting of Pancreatic Cancer SPOREUNIV OF NORTH CAROLINA CHAPEL HILL2022–2027
  • Integrating tumor and stroma to understand and predict treatment responseUNIV OF NORTH CAROLINA CHAPEL HILL2022–2027
  • Integrating tumor and stroma to understand and predict treatment responseUNIV OF NORTH CAROLINA CHAPEL HILL2022–2027
  • Pathway, Network and Spatiotemporal Integration of Cancer Genomics DataPRINCETON UNIVERSITY2021–2026
  • Pathway, Network and Spatiotemporal Integration of Cancer Genomics DataPRINCETON UNIVERSITY2021–2026
  • Targeting Ras-Ral Gef-Ral Effector Signaling For Pancreatic Cancer TreatmentNational Cancer Institute2010–2012
  • Nanoscale Metal-Organic Frameworks For Imaging And Therapy Of Pancreatic CancerNational Cancer Institute2010–2011

Professional Memberships

External Links

  • Researchhttps://unclineberger.org/yehlab

Dr. Jen Jen Yeh, Dr. Jen Jen Yeh, MD, Dr. J Yeh